I wrote an opinion piece for a journal but it was rejected.

I would like to put it on arxiv.org because now I do not have time to rewrite it, but I would like to circulate it. And, there are more important things to do. But, at some point I would like to submit a rewritten version to another venue. Which license should I choose on Arxiv?


  • 2
    I don't think you have given us enough information to make a significant choice. But in general if you're unsure it's probably best to go with the minimal non-exclusive license. Commented Aug 17, 2020 at 12:18
  • Do I understand correctly that all listed Creative Commons licenses allow the distribution of the paper in modified forms? If I do not want that, the first option allows only Arxiv to distribute the paper in unmodified form, right? Then that's my choice.
    – Gergely
    Commented Aug 17, 2020 at 12:29
  • @Gergely No, not all CC licenses permit modification: creativecommons.org/about/cclicenses
    – user2768
    Commented Aug 17, 2020 at 13:22
  • @user2768 I meant the listed ones that Arxiv allow
    – Gergely
    Commented Aug 17, 2020 at 13:43
  • 1
    Note that some venues may refuse a paper that has been posted to arXiv at all, regardless of what license was chosen. Commented Aug 17, 2020 at 20:02

1 Answer 1


I think there are two factors you will usually take into account:

  1. The policy of the journal or journals you expect to submit the work to. You must choose a license that is permitted by that journal. You can easily determine what is allowed using Sherpa/Romeo. Just search for the journal and look at what is allowed for "submitted version" (or accepted version) in a subject repository.

  2. Your own preferences. This is straightforward -- read the license and make sure you agree with what it allows/doesn't allow.

When in doubt, the minimal non-exclusive license is the safest bet: https://arxiv.org/licenses/nonexclusive-distrib/1.0/license.html


You must log in to answer this question.

Not the answer you're looking for? Browse other questions tagged .